Annual Total Long Term Liabilities
$14.40 M
+$2.35 M+19.53%
31 December 2023
Summary:
Castle Biosciences annual total long term liabilities is currently $14.40 million, with the most recent change of +$2.35 million (+19.53%) on 31 December 2023. During the last 3 years, it has risen by +$11.64 million (+421.70%). CSTL annual total long term liabilities is now -44.48% below its all-time high of $25.95 million, reached on 31 December 2021.CSTL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$29.21 M
+$5.25 M+21.91%
30 September 2024
Summary:
Castle Biosciences quarterly total long term liabilities is currently $29.21 million, with the most recent change of +$5.25 million (+21.91%) on 30 September 2024. Over the past year, it has increased by +$15.30 million (+110.00%). CSTL quarterly long term liabilities is now at all-time high.CSTL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.5% | +110.0% |
| 3 y3 years | +421.7% | +2863.0% |
| 5 y5 years | -44.0% | +35.1% |
CSTL Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -44.5% | +421.7% | at high | +2863.0% |
| 5 y | 5 years | -44.5% | +421.7% | at high | +2933.8% |
| alltime | all time | -44.5% | +421.7% | at high | +2933.8% |
Castle Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.21 M(+21.9%) |
| June 2024 | - | $23.96 M(-0.5%) |
| Mar 2024 | - | $24.09 M(+67.2%) |
| Dec 2023 | $14.40 M(+19.5%) | $14.40 M(+3.5%) |
| Sept 2023 | - | $13.91 M(+7.7%) |
| June 2023 | - | $12.91 M(+11.3%) |
| Mar 2023 | - | $11.60 M(-3.8%) |
| Dec 2022 | $12.05 M(-53.6%) | $12.05 M(-16.5%) |
| Sept 2022 | - | $14.44 M(+56.9%) |
| June 2022 | - | $9.20 M(+21.6%) |
| Mar 2022 | - | $7.57 M(-70.8%) |
| Dec 2021 | $25.95 M | $25.95 M(+2531.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $986.00 K(+2.4%) |
| June 2021 | - | $963.00 K(-17.5%) |
| Mar 2021 | - | $1.17 M(-57.7%) |
| Dec 2020 | $2.76 M(-85.7%) | $2.76 M(-79.7%) |
| Sept 2020 | - | $13.60 M(-13.3%) |
| June 2020 | - | $15.68 M(-8.1%) |
| Mar 2020 | - | $17.07 M(-11.8%) |
| Dec 2019 | $19.34 M(-24.8%) | $19.34 M(-10.6%) |
| Sept 2019 | - | $21.63 M(-14.2%) |
| June 2019 | - | $25.20 M(+6.4%) |
| Mar 2019 | - | $23.69 M(-8.0%) |
| Dec 2018 | $25.74 M(+36.4%) | $25.74 M |
| Dec 2017 | $18.87 M | - |
FAQ
- What is Castle Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Castle Biosciences?
- What is Castle Biosciences annual total long term liabilities year-on-year change?
- What is Castle Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Castle Biosciences?
- What is Castle Biosciences quarterly long term liabilities year-on-year change?
What is Castle Biosciences annual total long term liabilities?
The current annual total long term liabilities of CSTL is $14.40 M
What is the all time high annual total long term liabilities for Castle Biosciences?
Castle Biosciences all-time high annual total long term liabilities is $25.95 M
What is Castle Biosciences annual total long term liabilities year-on-year change?
Over the past year, CSTL annual total long term liabilities has changed by +$2.35 M (+19.53%)
What is Castle Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of CSTL is $29.21 M
What is the all time high quarterly long term liabilities for Castle Biosciences?
Castle Biosciences all-time high quarterly total long term liabilities is $29.21 M
What is Castle Biosciences quarterly long term liabilities year-on-year change?
Over the past year, CSTL quarterly total long term liabilities has changed by +$15.30 M (+110.00%)